Sanibel Captiva Trust Company Inc. Has $35.24 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sanibel Captiva Trust Company Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,292 shares of the healthcare conglomerate's stock after selling 1,724 shares during the period. UnitedHealth Group makes up about 1.1% of Sanibel Captiva Trust Company Inc.'s holdings, making the stock its 19th biggest position. Sanibel Captiva Trust Company Inc.'s holdings in UnitedHealth Group were worth $35,244,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new stake in UnitedHealth Group during the 4th quarter worth about $6,375,744,000. GAMMA Investing LLC grew its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi raised its holdings in shares of UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In other news, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 2.4%

Shares of UNH stock traded up $7.58 during trading hours on Thursday, reaching $318.14. The company had a trading volume of 15,588,566 shares, compared to its average volume of 7,136,756. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a 50 day moving average of $395.60 and a 200 day moving average of $478.20. The firm has a market cap of $288.60 billion, a price-to-earnings ratio of 20.53, a P/E/G ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the business earned $6.91 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.78%. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Wolfe Research dropped their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Truist Financial reiterated a "buy" rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, KeyCorp lowered their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.